These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3632139)

  • 21. Cibenzoline transforms random re-entry into ordered re-entry in the atria.
    Brugada J; Gürsoy S; Brugada P; Atié J; Guiraudon G; Andries E
    Eur Heart J; 1993 Feb; 14(2):267-72. PubMed ID: 8449204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of adenosine on impulse formation and propagation in the heart. Electrophysiologic studies and clinical implications.
    Solti F; Juhász-Nagy S; Kecskeméti V; Czakó E
    Cor Vasa; 1984; 26(4):296-303. PubMed ID: 6488803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
    Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
    Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophysiologic characterization of propafenone in man].
    Masini G; Dianda R; Masini M
    G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the novel class Ia and class III antiarrhythmic agent RS-87337 on myocardial conduction in the anaesthetised dog.
    Allely MC; Alps BJ
    Arch Int Pharmacodyn Ther; 1988; 295():138-46. PubMed ID: 3245729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiology of anterograde right-atrial and left-atrial inputs to the atrioventricular node in patients with atrioventricular nodal re-entrant tachycardia.
    Sinkovec M; Pernat A; Rajković Z; Jan M; Antolic B; Rakovec P
    Europace; 2011 Jun; 13(6):869-75. PubMed ID: 21186226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac effects of cibenzoline.
    Dangman KH
    J Cardiovasc Pharmacol; 1984; 6(2):300-11. PubMed ID: 6200720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscle.
    Masse C; Cazes M; Sassine A
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):219-35. PubMed ID: 6476980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of a new antiarrhythmic agent: cibenzoline.
    Rigaud M; Jouret G; Canal M; Bardet J; Flouvat B; Bourdarias JP
    J Pharmacol; 1985; 16(3):247-57. PubMed ID: 4068726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological effects of carocainide (770207) on the dog heart.
    Huerta F; Santamaria R; Pourrias B
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):289-98. PubMed ID: 6712362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of encainide and its two major metabolites on cardiac conduction.
    Dresel PE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainide.
    Lang J; Timour Q; Aupetit JF; Lancon JP; Lakhal M; Faucon G
    Arch Int Pharmacodyn Ther; 1988; 293():97-108. PubMed ID: 3138954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac electrophysiological effects of cibenzoline in the conscious dog: plasma concentration-response relationships.
    Boucher M; Dubray C; Kantelip JP; Talmant JM; Dufour A; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):616-21. PubMed ID: 2478775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of verapamil on electrophysiologic properties of blood superfused cardiac Purkinje fibers.
    Danilo P; Hordof AJ; Reder RF; Rosen MR
    J Pharmacol Exp Ther; 1980 May; 213(2):222-7. PubMed ID: 7365685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia.
    Cocco G; Strozzi C; Pansini R; Rochat N; Bulgarelli R; Padula A; Sfrisi C; Kamal Al Yassini A
    Eur Heart J; 1984 Feb; 5(2):108-14. PubMed ID: 6723683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hypoxia on the use-dependent inhibition of conduction velocity induced by cibenzoline in guinea pig ventricular myocardium.
    Hasegawa J; Watanabe M; Kaneda T; Osaki S; Hisatome I; Kotake H; Mashiba H
    J Clin Pharmacol; 1993 May; 33(5):444-9. PubMed ID: 8331201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline.
    Kakugawa H; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kanemoto M; Matsuzaki M
    Circ J; 2003 Oct; 67(10):810-5. PubMed ID: 14578610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The electrophysiologic effects of oral cibenzoline.
    Kushner M; Magiros E; Peters R; Carliner N; Plotnick G; Fisher M
    J Electrocardiol; 1984 Jan; 17(1):15-23. PubMed ID: 6199450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.